MIRM
Mirum Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$116.62-1.88%
Price as of Jul 20, 2026
MIRM profitability
Mirum Pharmaceuticals, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 81.4%
- EBITDA margin
- -133.6%
- EBIT margin
- -12.3%
- Net margin
- -140.2%
- Free cash flow margin
- -30.3%
Returns
- Return on equity
- -329.4%
- Return on assets
- -89.7%
- Return on invested capital
- -12.4%
- Asset turnover
- 0.66x
Cash efficiency
- Cash from operations
- -$171.0M
- Cash per share
- $6.33
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.